Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00730_DB01142_nanopub.RAmbHar4mlxVYL4IkKnXBF4Ibwn-EzOzEj26-VjLNwTKg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00730_DB01142 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00730_DB01142 label "DDI between Thiabendazole and Doxepin - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Doxepin by decreasing Doxepin metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Doxepin if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00730_DB01142]" assertion.
- drugbank_resource:DB00730_DB01142 identifier "drugbank_resource:DB00730_DB01142" assertion.
- drugbank_resource:DB00730_DB01142 title "DDI between Thiabendazole and Doxepin - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Doxepin by decreasing Doxepin metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Doxepin if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB01142 assertion.
- drugbank:DB01142 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB01142 assertion.